Epigenetic regulation of pregnane X receptor activity

References

• Adelman K, Lis JT. (2012). Promoter-proximal pausing of RNA polymerase II: Emerging roles in metazoans. Nat Rev Genet 13:720–731
   PubMed Web of Science ®Google Scholar
• Bartel DP. (2009). MicroRNAs: Target recognition and regulatory functions. Cell 136:215–233
   PubMed Web of Science ®Google Scholar
• Beck F, Stringer EJ. (2010). The role of Cdx genes in the gut and in axial development. Biochem Soc Transact 38:353–357
   PubMed Web of Science ®Google Scholar
• Behm-Ansmant I, Rehwinkel J, Doerks T, et al. (2006). mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 20:1885–1898
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Meissner A, Lander ES. (2007). The mammalian epigenome. Cell 128:669–681
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Heidrich J, Svensson K, et al. (1998). Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208–12213
   PubMed Web of Science ®Google Scholar
• Bhalla S, Ozalp C, Fang S, et al. (2004). Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem 279:45139–45147
   PubMed Web of Science ®Google Scholar
• Biswas A, Pasquel D, Tyagi RK, Mani S. (2011). Acetylation of pregnane X receptor protein determines selective function independent of ligand activation. Biochem Biophys Res Commun 406:371–376
   PubMed Web of Science ®Google Scholar
• Blumberg B, Sabbagh W, Jr., Juguilon H, et al. (1998). SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195–3205
   PubMed Web of Science ®Google Scholar
• Bulynko YA, O'Malley BW. (2011). Nuclear receptor coactivators: Structural and functional biochemistry. Biochemistry 50:313–328
   PubMed Web of Science ®Google Scholar
• Chen Y, Tang, Y, Guo, C, et al. (2012). Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol 83:1112–1126
   PubMed Web of Science ®Google Scholar
• Cheng J, Shah YM, Gonzalez FJ. (2012). Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci 33:323–330
   PubMed Web of Science ®Google Scholar
• Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD. (2010). ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res 38:7943–7963
   PubMed Web of Science ®Google Scholar
• Dannenberg LO, Edenberg HJ. (2006). Epigenetics of gene expression in human hepatoma cells: Expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 7:181
   PubMed Web of Science ®Google Scholar
• de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. (1999). Cytochrome P450 3A: Ontogeny and drug disposition. Clin Pharmacokinet 37:485–505
   PubMed Web of Science ®Google Scholar
• Di Lorenzo A, Bedford MT. (2011). Histone arginine methylation. FEBS Lett 585:2024–2031
   PubMed Web of Science ®Google Scholar
• Doidge R, Mittal S, Aslam A, Winkler GS. (2012). Deadenylation of cytoplasmic mRNA by the mammalian Ccr4-Not complex. Biochem Soc Transact 40:896–901
   PubMed Web of Science ®Google Scholar
• Dou W, Mukherjee S, Li H, et al. (2012). Alleviation of gut inflammation by cdx2/pxr pathway in a mouse model of chemical colitis. PloS One 7:e36075
   PubMed Web of Science ®Google Scholar
• Gao J, Xie W. (2012). Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci 33:552–558
   PubMed Web of Science ®Google Scholar
• Garber M, Yosef N, Goren A, et al. (2012). A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell 47:810–822
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. (1999). The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329–1339
   PubMed Web of Science ®Google Scholar
• Gu X, Ke S, Liu D, et al. (2006). Role of NF-kappaB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281:17882–17889
   PubMed Web of Science ®Google Scholar
• Habano W, Gamo T, Terashima J, et al. (2011). Involvement of promoter methylation in the regulation of pregnane X receptor in colon cancer cells. BMC Cancer 11:81
   PubMed Web of Science ®Google Scholar
• Hu G, Xu C, Staudinger JL. (2010). Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther 335:342–350
   PubMed Web of Science ®Google Scholar
• Huang S, Litt M, Felsenfeld G. (2005). Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev 19:1885–1893
   PubMed Web of Science ®Google Scholar
• Hwang-Verslues WW, Sladek FM. (2010). HNF4alpha – role in drug metabolism and potential drug target? Curr Opin Pharmacol 10:698–705
   PubMed Web of Science ®Google Scholar
• Ihunnah CA, Jiang M, Xie W. (2011). Nuclear receptor PXR, transcriptional circuits, and metabolic relevance. Biochim Biophys Acta 1812:956–963
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. (2001). Translating the histone code. Science 293:1074–1080
   PubMed Web of Science ®Google Scholar
• Jonker JW, Liddle C, Downes M. (2012). FXR and PXR: Potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 130:147–158
   PubMed Web of Science ®Google Scholar
• Kato S, Yokoyama A, Fujiki R. (2011). Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. Trends Biochem Sci 36:272–281
   PubMed Web of Science ®Google Scholar
• King-Jones K, Horner MA, Lam G, Thummel CS. (2006). The DHR96 nuclear receptor regulates xenobiotic responses in Drosophila. Cell Metab 4:37–48
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Moore JT, Wade L, et al. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Willson TM. (2002). Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43:359–364
   PubMed Web of Science ®Google Scholar
• Klose RJ, Zhang Y. (2007). Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8:307–318
   PubMed Web of Science ®Google Scholar
• Kodama S, Hosseinpour F, Goldstein JA, Negishi M. (2011). Liganded pregnane X receptor represses the human sulfotransferase SULT1E1 promoter through disrupting its chromatin structure. Nucleic Acids Res 39:8392–8403
   PubMed Web of Science ®Google Scholar
• Kuehner JN, Pearson EL, Moore C. (2011). Unravelling the means to an end: RNA polymerase II transcription termination. Nat Rev Mol Cell Biol 12:283–294
   PubMed Web of Science ®Google Scholar
• Law ME, Corsino PE, Jahn SC, et al. (2012). Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. Oncogene Apr 30 doi: 10.1038/onc.2012.138
   Google Scholar
• Lehmann JM, McKee DD, Watson MA, et al. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–1023
   PubMed Web of Science ®Google Scholar
• Levine M. (2011). Paused RNA polymerase II as a developmental checkpoint. Cell 145:502–511
   PubMed Web of Science ®Google Scholar
• Li T, Yu RT, Atkins AR, et al. (2012). Targeting the pregnane X receptor in liver injury. Expert Opin Ther Targets 16:1075–1083
   PubMed Web of Science ®Google Scholar
• Li Y, Cui Y, Hart SN, et al. (2009). Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol 75:1171–1179
   PubMed Web of Science ®Google Scholar
• Lichti-Kaiser K, Brobst D, Xu C, Staudinger JL. (2009a). A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein. J Pharmacol Exp Ther 331:65–76
   PubMed Web of Science ®Google Scholar
• Lichti-Kaiser K, Xu C, Staudinger JL. (2009b). Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner. J Biol Chem 284:6639–6649
   PubMed Web of Science ®Google Scholar
• Liu FJ, Song X, Yang D, et al. (2008). The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha. Biochem J 409:243–250
   PubMed Web of Science ®Google Scholar
• Masuyama H, Hiramatsu Y, Mizutani Y, et al. (2001). The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell Endocrinol 172:47–56
   PubMed Web of Science ®Google Scholar
• Masuyama H, Inoshita H, Hiramatsu Y, Kudo T. (2002). Ligands have various potential effects on the degradation of pregnane X receptor by proteasome. Endocrinology 143:55–61
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito T, Takahashi Y, et al. (2004). Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 65:326–334
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Tazawa C, et al. (2005). Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 231:75–85
   PubMed Web of Science ®Google Scholar
• Muse GW, Gilchrist DA, Nechaev S, et al. (2007). RNA polymerase is poised for activation across the genome. Nature Genetics 39:1507–1511
   PubMed Web of Science ®Google Scholar
• Navaratnarajah P, Steele BL, Redinbo MR, Thompson NL. (2012). Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins. Biochemistry 51:19–31
   PubMed Web of Science ®Google Scholar
• Orans J, Teotico DG, Redinbo MR. (2005). The nuclear xenobiotic receptor pregnane X receptor: Recent insights and new challenges. Mol Endocrinol 19:2891–2900
   PubMed Web of Science ®Google Scholar
• Pan YZ, Gao W, Yu AM. (2009). MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112–2117
   PubMed Web of Science ®Google Scholar
• Pondugula SR, Dong H, Chen T. (2009). Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression. Expert Opin Drug Metab Toxicol 5:861–873
   PubMed Web of Science ®Google Scholar
• Ramaswamy B, Fiskus W, Cohen B, et al. (2012). Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: Evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat 132:1063–1072
   PubMed Web of Science ®Google Scholar
• Squires EJ, Sueyoshi T, Negishi M. (2004). Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 279:49307–49314
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Xu C, Biswas A, Mani S. (2011). Post-translational modification of pregnane x receptor. Pharmacol Res 64:4–10
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. (2000). The language of covalent histone modifications. Nature 403:41–45
   PubMed Web of Science ®Google Scholar
• Takagi S, Nakajima M, Mohri T, Yokoi T. (2008). Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674–9680
   PubMed Web of Science ®Google Scholar
• Tang Q, Chen Y, Meyer C, et al. (2011). A comprehensive view of nuclear receptor cancer cistromes. Cancer Res 71:6940–6947
   PubMed Web of Science ®Google Scholar
• Tian Y. (2009). Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem Pharmacol 77:670–680
   PubMed Web of Science ®Google Scholar
• Tian Y, Ke S, Chen M, Sheng T. (2003). Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J Biol Chem 278:44041–44048
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, et al. (2003). The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220–224
   PubMed Web of Science ®Google Scholar
• Tolhuis B, Palstra RJ, Splinter E, et al. (2002). Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 10:1453–1465
   PubMed Web of Science ®Google Scholar
• Wada T, Gao J, Xie W. (2009). PXR and CAR in energy metabolism. Trends Endocrinol Metab 20:273–279
   PubMed Web of Science ®Google Scholar
• Wang H, Huang ZQ, Xia L, et al. (2001). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:853–857
   PubMed Web of Science ®Google Scholar
• Winkler GS, Mulder KW, Bardwell VJ, et al. (2006). Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. EMBO J 25:3089–3099
   PubMed Web of Science ®Google Scholar
• Wu SC, Zhang Y. (2009). Minireview: Role of protein methylation and demethylation in nuclear hormone signaling. Mol Endocrinol 23:1323–1334
   PubMed Web of Science ®Google Scholar
• Xie W, Radominska-Pandya A, Shi Y, et al. (2001). An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A 98:3375–3380
   PubMed Web of Science ®Google Scholar
• Xie Y, Ke S, Ouyang N, et al. (2009). Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1. J Biol Chem 284:9199–9205
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu Y, Espejo A, et al. (2010). TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell 40:1016–1023
   Google Scholar
• Zhou C, Tabb MM, Nelson EL, et al. (2006). Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116:2280–2289
   PubMed Web of Science ®Google Scholar
• Zhou C, Verma S, Blumberg B. (2009). The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal 7:e001
   PubMedGoogle Scholar